Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Net Income (2016 - 2020)

Historic Net Income for Conmed (CNMD) over the last 11 years, with Q4 2020 value amounting to $135.5 million.

  • Conmed's Net Income fell 455.08% to $135.5 million in Q4 2020 from the same period last year, while for Sep 2021 it was $135.5 million, marking a year-over-year decrease of 7096.72%. This contributed to the annual value of $47.1 million for FY2025, which is 6446.61% down from last year.
  • Latest data reveals that Conmed reported Net Income of $135.5 million as of Q4 2020, which was down 455.08% from $133.7 million recorded in Q3 2020.
  • In the past 5 years, Conmed's Net Income registered a high of $142.0 million during Q4 2019, and its lowest value of $71.9 million during Q2 2020.
  • Over the past 5 years, Conmed's median Net Income value was $113.4 million (recorded in 2018), while the average stood at $114.5 million.
  • In the last 5 years, Conmed's Net Income skyrocketed by 1761.23% in 2019 and then plummeted by 4517.19% in 2020.
  • Conmed's Net Income (Quarter) stood at $107.0 million in 2016, then increased by 15.89% to $124.0 million in 2017, then grew by 7.02% to $132.7 million in 2018, then grew by 7.03% to $142.0 million in 2019, then decreased by 4.55% to $135.5 million in 2020.
  • Its Net Income stands at $135.5 million for Q4 2020, versus $133.7 million for Q3 2020 and $71.9 million for Q2 2020.